Publication | Closed Access
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
51
Citations
30
References
2023
Year
HepatologyHepatocellular CarcinomaMedicinePharmacologyTransarterial ChemoembolizationPharmacotherapyPd-1 InhibitorLiver CancerAnti-cancer AgentOncologyRadiation OncologyUnresectable Hepatocellular CarcinomaTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1